secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVAI BIO, INC. (AVAI)
CIK:        0001740797
Form:       8-K
Filed at:   2024-01-31T23:59:59+00:00
Accession:  0001740797-24-000007
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avant Technologies appoints Angela Harris as COO effective Feb 1, 2024
----------------------------------------------------------------------

- Annual base salary of $275,000 plus cash bonus up to 35% of base, accrued until company raises funds.
- Initial ISO grant of 2% of outstanding common stock at $0.01 strike, 4-year vesting with 1-year cliff.
- One-time RSA bonus of $500,000 if listed on Nasdaq or other national exchange, payable in shares at 15% discount to VWAP.
- Cash compensation and bonuses accrued and paid within 5 business days after sufficient funds are raised.
- Mrs. Harris will report to the President/CEO/CFO and be part of Senior Management Team.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1740797/000174079724000007/0001740797-24-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1740797/000174079724000007/form8k_avai.htm
  HTML page:      https://secwatch.observer/filing/0001740797-24-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer